MAPK3 and central nervous system cancer: A difference in the levels of inducible JNK1/2 activities between U87MG and U118MG cells was maintained after overnight treatment; furthermore, levels of ERK1/2 activities were decreased in both glioma lines after overnight treatment (Figure 1C).